HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fang Zheng Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2022DYSF promotes monocyte activation in atherosclerotic cardiovascular disease as a DNA methylation-driven gene.
1/2020Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular Disease.
6/2019Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fang Zheng Research Topics

Disease

79Neoplasms (Cancer)
01/2022 - 03/2004
25Inflammation (Inflammations)
02/2022 - 01/2007
23Cocaine-Related Disorders (Cocaine Addiction)
01/2022 - 03/2013
23Lung Neoplasms (Lung Cancer)
01/2020 - 01/2013
17Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 10/2010
16COVID-19
01/2022 - 01/2020
16Hepatocellular Carcinoma (Hepatoma)
10/2020 - 04/2009
10Rheumatoid Arthritis
07/2019 - 01/2010
9Infections
03/2022 - 01/2009
9Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 04/2005
9Hepatitis
12/2020 - 01/2010
9Seizures (Absence Seizure)
01/2017 - 04/2007
8Breast Neoplasms (Breast Cancer)
01/2020 - 04/2004
8Alzheimer Disease (Alzheimer's Disease)
08/2019 - 11/2004
7Atherosclerosis
01/2022 - 01/2006
6Prostatic Neoplasms (Prostate Cancer)
12/2021 - 11/2016
6Pain (Aches)
11/2021 - 02/2010
6Neoplasm Metastasis (Metastasis)
04/2021 - 02/2009
6Carcinogenesis
01/2020 - 09/2005
6Coronary Disease (Coronary Heart Disease)
01/2014 - 04/2004
5Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
11/2022 - 03/2015
5Type 2 Diabetes Mellitus (MODY)
07/2021 - 12/2005
5Parkinson Disease (Parkinson's Disease)
01/2021 - 08/2009
5Autoimmune Diseases (Autoimmune Disease)
01/2021 - 12/2010
5Multiple Sclerosis
01/2021 - 02/2012
5Substance-Related Disorders (Drug Abuse)
10/2020 - 01/2012
5Melanoma (Melanoma, Malignant)
11/2018 - 09/2011
5Cataract (Cataracts)
06/2015 - 03/2008
4Body Weight (Weight, Body)
09/2022 - 01/2008
4Fibrosis (Cirrhosis)
03/2021 - 01/2021
4Schizophrenia (Dementia Praecox)
02/2021 - 06/2012
4Disease Progression
01/2020 - 01/2009
4Nasopharyngeal Carcinoma
01/2019 - 07/2014
4Colitis
01/2019 - 07/2012
4Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
08/2018 - 02/2008
4Ischemia
01/2018 - 06/2008
4Ovarian Neoplasms (Ovarian Cancer)
07/2004 - 11/2002
3Demyelinating Diseases (Demyelinating Disease)
11/2022 - 01/2018
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 06/2019
3Hypoxia (Hypoxemia)
01/2022 - 09/2016
3Stomach Neoplasms (Stomach Cancer)
04/2021 - 09/2016

Drug/Important Bio-Agent (IBA)

51Proteins (Proteins, Gene)FDA Link
02/2022 - 12/2002
21Pharmaceutical PreparationsIBA
06/2022 - 11/2009
19Biomarkers (Surrogate Marker)IBA
06/2022 - 02/2011
19Cocaine (Cocaine HCl)IBA
01/2022 - 03/2013
15EnzymesIBA
01/2022 - 12/2011
14HMGB1 Protein (HMG1)IBA
11/2022 - 06/2008
13CytokinesIBA
01/2022 - 12/2012
12Biological ProductsIBA
09/2022 - 09/2011
12DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2006
11MicroRNAs (MicroRNA)IBA
06/2020 - 02/2012
10Messenger RNA (mRNA)IBA
01/2022 - 04/2009
10Interleukin-33IBA
01/2021 - 07/2012
9Retinaldehyde (Retinal)IBA
04/2021 - 01/2017
8Long Noncoding RNAIBA
01/2020 - 01/2015
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022 - 03/2004
6Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2018
6Immunoglobulin G (IgG)IBA
12/2020 - 08/2014
6Cisplatin (Platino)FDA LinkGeneric
01/2020 - 11/2002
6Pilocarpine (Ocusert)FDA LinkGeneric
01/2017 - 08/2009
5C-Reactive ProteinIBA
01/2021 - 02/2007
5Interleukin-10 (Interleukin 10)IBA
10/2020 - 01/2007
5cocaine hydrolaseIBA
01/2020 - 05/2014
5oxidized low density lipoproteinIBA
06/2019 - 04/2004
5p38 Mitogen-Activated Protein KinasesIBA
01/2019 - 04/2014
5Concanavalin AIBA
01/2017 - 01/2010
5MethyltransferasesIBA
01/2017 - 03/2015
4Glucose (Dextrose)FDA LinkGeneric
09/2022 - 12/2005
4VaccinesIBA
01/2022 - 04/2012
4Therapeutic UsesIBA
01/2021 - 01/2016
4Interleukin-17 (Interleukin 17)IBA
01/2021 - 01/2011
4BerberineIBA
01/2021 - 04/2014
4CollagenIBA
01/2021 - 01/2005
4LipidsIBA
01/2020 - 08/2013
4beta-solamarineIBA
11/2019 - 12/2015
4ErbB Receptors (EGF Receptor)IBA
07/2019 - 01/2014
4CalreticulinIBA
07/2019 - 07/2013
4ApolipoproteinsIBA
06/2019 - 11/2004
4Apolipoproteins E (ApoE)IBA
06/2019 - 04/2004
4Dinoprostone (PGE2)FDA Link
01/2019 - 12/2013
4LDL Receptors (LDL Receptor)IBA
08/2018 - 02/2008
4Amyloid (Amyloid Fibrils)IBA
01/2018 - 01/2014
4Single-Domain AntibodiesIBA
01/2017 - 05/2014
4Ursolic AcidIBA
05/2016 - 04/2015
4AntigensIBA
01/2016 - 04/2012
4Caspase 3 (Caspase-3)IBA
07/2004 - 11/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2022 - 04/2016
3Monoclonal AntibodiesIBA
01/2022 - 10/2018
3NucleotidesIBA
01/2022 - 07/2019
3Antineoplastic Agents (Antineoplastics)IBA
11/2021 - 01/2014
3Analgesics (Analgesic Drugs)IBA
11/2021 - 07/2015
3pristane (pristan)IBA
01/2021 - 01/2010
3Antiviral Agents (Antivirals)IBA
01/2021 - 01/2020
3Immunoglobulin M (IgM)IBA
12/2020 - 02/2018
3AntibodiesIBA
12/2020 - 01/2017
3Adrenal Cortex Hormones (Corticosteroids)IBA
11/2020 - 01/2018

Therapy/Procedure

36Therapeutics
01/2022 - 11/2009
6Drug Therapy (Chemotherapy)
01/2020 - 12/2002
4Immunotherapy
01/2022 - 04/2012
4Radiofrequency Ablation
02/2017 - 10/2010